These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7470609)

  • 1. [Prevention of experimental allergic encephalomyelitis in guinea pigs by treatment with magnetophores].
    Zhitnukhin IuL; Zatepiakin IuS; Karasik OA
    Biull Eksp Biol Med; 1980 Dec; 90(12):713-5. PubMed ID: 7470609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective action of antioxidant preparations on the development of experimental allergic encephalomyelitis in guinea pigs].
    Kryzhanovskiĭ GN; Vilkov GA; Stepanenko EM
    Biull Eksp Biol Med; 1984 Nov; 98(11):527-30. PubMed ID: 6509167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
    Matsumoto Y; Tsuchida M; Hanawa H; Abo T
    Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F; Mason D
    Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of immunoadsorbent treatment in experimental allergic encephalomyelitis].
    Hurina NM; Bardakhivs'ka KI; Kuchmerovs'ka TM
    Fiziol Zh (1994); 2008; 54(6):79-86. PubMed ID: 19227244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of vitamin E and thymalin on the development of experimental allergic encephalomyelitis].
    Vilkov GA; Stepanenko EM; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1987 Sep; 104(9):288-90. PubMed ID: 3663910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental autoimmune encephalomyelitis in Lewis rats: IFN-beta acts as a tolerogenic adjuvant for induction of neuroantigen-dependent tolerance.
    Mannie MD; Abbott DJ; Blanchfield JL
    J Immunol; 2009 May; 182(9):5331-41. PubMed ID: 19380780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental allergic encephalomyelitis in guinea-pigs with poly-L-lysine.
    Chelmicka-Szorc E; Arnason BG
    Clin Exp Immunol; 1975 Dec; 22(3):539-45. PubMed ID: 5213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological studies on experimental allergic encephalomyelitis (EAE). Protection against EAE (author's transl)].
    Nagasawa K
    Fukuoka Igaku Zasshi; 1976 Jun; 67(6):220-33. PubMed ID: 986997
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of allergic responses of peripheral blood leukocytes in the pathogenesis of experimental allergic (pertussis) encephalomyelitis].
    Kanchurin AKh; Babakhin AA; Safronova AV
    Biull Eksp Biol Med; 1977 Mar; 83(3):320-4. PubMed ID: 851635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA; Kamoun M; Ventura E; Rostami A
    Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
    Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
    Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites.
    Malfroy B; Doctrow SR; Orr PL; Tocco G; Fedoseyeva EV; Benichou G
    Cell Immunol; 1997 Apr; 177(1):62-8. PubMed ID: 9140096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU; Bartlett RR
    Drugs Exp Clin Res; 1997; 23(5-6):175-81. PubMed ID: 9515227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
    Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
    J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of immunological tolerance to brain antigens as a means of specific prevention and treatment of experimental allergic encephalomyelitis].
    Reber NV
    Biull Eksp Biol Med; 1971 Nov; 72(11):69-73. PubMed ID: 5131039
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
    Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
    J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of myo-inositol on the induction of experimental allergic encephalomyelitis in guinea pigs.
    Tsumita T; Saito M; Nagai Y
    Jpn J Exp Med; 1972 Dec; 42(6):587-8. PubMed ID: 4540909
    [No Abstract]   [Full Text] [Related]  

  • 20. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.